|
GB1421108A
(en)
*
|
1973-09-07 |
1976-01-14 |
Exxon Research Engineering Co |
Sulphurised phenols
|
|
NZ205559A
(en)
*
|
1982-09-23 |
1987-08-31 |
Merck Frosst Canada Inc |
Leukotriene antagonists, pharmaceutical compositions, and intermediates
|
|
EP0106565B1
(en)
*
|
1982-09-30 |
1986-09-10 |
Merck Frosst Canada Inc. |
Leukotriene antagonists, their production, and compositions containing them
|
|
DE3565400D1
(en)
*
|
1984-02-03 |
1988-11-10 |
Ciba Geigy Ag |
Di-(substituted hydroxyphenylthio)-alkanes and cycloalkanes and compositions containing them
|
|
US4560799A
(en)
*
|
1984-02-03 |
1985-12-24 |
Ciba-Geigy Corporation |
Tri- and Tetra-(substituted hydroxyphenylthio) alkane and cycloalkane stabilizers and stabilized compositions
|
|
CA1339222C
(en)
*
|
1987-01-20 |
1997-08-05 |
Merrell Dow Pharmaceuticals Inc. |
Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol)
|
|
US5401883A
(en)
*
|
1987-01-20 |
1995-03-28 |
Merrell Dow Pharmaceuticals Inc. |
Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol)
|
|
US4975467A
(en)
*
|
1987-03-17 |
1990-12-04 |
Merrell Dow Pharmaceuticals Inc. |
Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
|
|
US4954528A
(en)
*
|
1988-12-08 |
1990-09-04 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
|
|
US4900757A
(en)
*
|
1988-12-08 |
1990-02-13 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
|
|
DE69031913T2
(de)
*
|
1989-07-14 |
1998-07-09 |
Biodor Us Holding Corp |
Antivirale mittel
|
|
US4959392A
(en)
*
|
1989-07-24 |
1990-09-25 |
Merrell Dow Pharmaceuticals Inc. |
Method of treating diabetes mellitus
|
|
US5677291A
(en)
*
|
1993-12-10 |
1997-10-14 |
Hoechst Marion Roussel, Inc. |
Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
|
|
US5795876A
(en)
*
|
1996-04-30 |
1998-08-18 |
Hoechst Marion Rousssel, Inc. |
Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
|
|
US6114572A
(en)
*
|
1996-11-20 |
2000-09-05 |
Hoechst Marion Roussel, Inc. |
Substituted phenols and thiophenols useful as antioxidant agents
|
|
AU2002300328B2
(en)
*
|
1997-05-14 |
2006-04-13 |
Atherogenics, Inc |
Compounds and methods for the inhibition of the expression of VCAM-1
|
|
US6852878B2
(en)
|
1998-05-14 |
2005-02-08 |
Atherogenics, Inc. |
Thioketals and thioethers for inhibiting the expression of VCAM-1
|
|
US6670398B2
(en)
|
1997-05-14 |
2003-12-30 |
Atherogenics, Inc. |
Compounds and methods for treating transplant rejection
|
|
AU2006202461B2
(en)
*
|
1997-05-14 |
2009-12-03 |
Atherogenics, Inc. |
Compositions and methods for the inhibition of the expression of VCAM-1
|
|
ES2283933T3
(es)
|
1997-05-14 |
2007-11-01 |
Atherogenics, Inc. |
Ester del acido succinico de probucol para la inhibicion de la expresion de vcam-1.
|
|
EP1695959A1
(en)
*
|
1997-05-14 |
2006-08-30 |
Atherogenics, Inc. |
Compouds and methods for the inhibition of the expression of VCAM-1
|
|
US6121463A
(en)
*
|
1997-06-24 |
2000-09-19 |
Hoechst Marion Roussel, Inc. |
Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
|
|
US6133467A
(en)
*
|
1997-06-25 |
2000-10-17 |
Hoechst Marion Roussel, Inc. |
2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
|
|
US20070260087A1
(en)
|
2004-04-20 |
2007-11-08 |
Atherogenics, Inc. |
Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
|
|
EP1844009A4
(en)
*
|
2004-12-17 |
2010-04-21 |
Roland O Stocker |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF CARDIAC DISORDER
|
|
US8252840B2
(en)
|
2007-03-26 |
2012-08-28 |
Salutria Pharmaceuticals Llc |
Methods of derivatives of probucol for the treatment of type II diabetes
|